Tags

Type your tag names separated by a space and hit enter

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial.
Biol Psychiatry. 1996 Feb 01; 39(3):213-5.BP

Authors+Show Affiliations

Department of Psychiatry, Albert Einstein College of Medicine/Bronx Psychiatric Center, Bronx, New York, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

8837983

Citation

Leiderman, E, et al. "Preliminary Investigation of High-dose Oral Glycine On Serum Levels and Negative Symptoms in Schizophrenia: an Open-label Trial." Biological Psychiatry, vol. 39, no. 3, 1996, pp. 213-5.
Leiderman E, Zylberman I, Zukin SR, et al. Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial. Biol Psychiatry. 1996;39(3):213-5.
Leiderman, E., Zylberman, I., Zukin, S. R., Cooper, T. B., & Javitt, D. C. (1996). Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial. Biological Psychiatry, 39(3), 213-5.
Leiderman E, et al. Preliminary Investigation of High-dose Oral Glycine On Serum Levels and Negative Symptoms in Schizophrenia: an Open-label Trial. Biol Psychiatry. 1996 Feb 1;39(3):213-5. PubMed PMID: 8837983.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial. AU - Leiderman,E, AU - Zylberman,I, AU - Zukin,S R, AU - Cooper,T B, AU - Javitt,D C, PY - 1996/2/1/pubmed PY - 1996/2/1/medline PY - 1996/2/1/entrez SP - 213 EP - 5 JF - Biological psychiatry JO - Biol Psychiatry VL - 39 IS - 3 SN - 0006-3223 UR - https://www.unboundmedicine.com/medline/citation/8837983/Preliminary_investigation_of_high_dose_oral_glycine_on_serum_levels_and_negative_symptoms_in_schizophrenia:_an_open_label_trial_ L2 - https://linkinghub.elsevier.com/retrieve/pii/0006-3223(95)00585-4 DB - PRIME DP - Unbound Medicine ER -